Class Certified In McKesson Drug Pricing Case

Law360, New York (August 30, 2007, 12:00 AM EDT) -- A federal court judge has granted class status to a group of plaintiffs that brought suit against McKesson Corp. alleging the pharmaceutical distributor conspired to raise the average wholesale price for thousands of drugs.

Judge Patti B. Saris of the U.S. District Court for the District of Massachusetts certified two classes on Monday, consumers that purchased one of the brand-name drugs, and third-party payors, typically large insurers or smaller health and welfare plans that reimburse patients for medications.

The plaintiffs allege that McKesson, the largest pharmaceutical...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.